Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target

Cancer Commun (Lond). 2021 Dec 4. doi: 10.1002/cac2.12240. Online ahead of print.
No abstract available

Publication types

  • Letter